Senate Democrats Want Probe of HHS Nominee Price’s Stock Trades
- Report said health bills he championed aided portfolio
- They seek probe by House ethics office GOP attempted to limit
U.S. Tom Price (R-GA) (R) arrives at a House Republican Conference meeting June 22, 2016 at the Capitol in Washington, DC. House GOPs held a conference meeting to discuss the current situation of a gun control sit-in protest on the House floor staged by House Democrat.
Photographer: Alex Wong/Getty ImagesThis article is for subscribers only.
Senate Democrats called for a delay in confirmation hearings for Representative Tom Price, Donald Trump’s pick to be secretary of Health and Human Services, for an investigation of his trades in health-care stocks while handling legislation that could affect the shares.
“He did this repeatedly and in such large numbers he’s likely to have made tens of thousands of dollars in one trade alone,” Senate Minority Leader Chuck Schumer, a New York Democrat, said at a news conference.